BioAffinity Technologies Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About BioAffinity Technologies Inc.
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company’s product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
/ 
Frequently asked questions
To buy BioAffinity Technologies Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for BioAffinity Technologies Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for BioAffinity Technologies Inc. is BIAF:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
BioAffinity Technologies Inc. has its primary listing on NASDAQ (Small cap). You can trade BioAffinity Technologies Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, BioAffinity Technologies Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include BioAffinity Technologies Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like BioAffinity Technologies Inc..